EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Alisertib Induces Cell Cycle Arrest and Autophagy and Suppresses Epithelial-to-Mesenchymal Transition Involving PI3K/Akt/mTOR and Sirtuin 1-Mediated signaling pathways in Human Pancreatic Cancer Cells [Retraction]

Feng Wang, Hai Li, Xiao-Gang Yan, Zhi-Wei Zhou, Zhi-Gang Yi, Zhi-Xu He, Shu-Ting Pan, Yin-Xue Yang, Zuo-Zheng Wang, Xueji Zhang, Tianxing Yang, Jia-Xuan Qiu und 1 weitere

Drug Design, Development and Therapy · 2026-06 · Volume 20 · 1-2

DOI: 10.2147/dddt.s633636 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-06. Verfasst von Feng Wang und 12 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Wang, F., Li, H., Yan, X., Zhou, Z., Yi, Z., He, Z., Pan, S., Yang, Y., Wang, Z., Zhang, X., Yang, T., Qiu, J., & Zhou, S. S. (2026). Alisertib Induces Cell Cycle Arrest and Autophagy and Suppresses Epithelial-to-Mesenchymal Transition Involving PI3K/Akt/mTOR and Sirtuin 1-Mediated signaling pathways in Human Pancreatic Cancer Cells [Retraction]. Drug Design, Development and Therapy, Volume 20, 1-2. https://doi.org/10.2147/dddt.s633636

Vancouver

Wang F, Li H, Yan X, Zhou Z, Yi Z, He Z, et al. Alisertib Induces Cell Cycle Arrest and Autophagy and Suppresses Epithelial-to-Mesenchymal Transition Involving PI3K/Akt/mTOR and Sirtuin 1-Mediated signaling pathways in Human Pancreatic Cancer Cells [Retraction]. Drug Design, Development and Therapy. 2026;Volume 20:1-2. doi:10.2147/dddt.s633636

BibTeX
@article{Wang2026,
  author = {Wang, Feng and Li, Hai and Yan, Xiao-Gang and Zhou, Zhi-Wei and Yi, Zhi-Gang and He, Zhi-Xu and Pan, Shu-Ting and Yang, Yin-Xue and Wang, Zuo-Zheng and Zhang, Xueji and Yang, Tianxing and Qiu, Jia-Xuan and Zhou, Shu-Feng S},
  title = {Alisertib Induces Cell Cycle Arrest and Autophagy and Suppresses Epithelial-to-Mesenchymal Transition Involving PI3K/Akt/mTOR and Sirtuin 1-Mediated signaling pathways in Human Pancreatic Cancer Cells [Retraction]},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--2},
  doi = {10.2147/dddt.s633636}
}
Kostenlos starten →